Ngl Fine-Chem Limited

BSE: 524774
Ngl Fine-Chem Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials and compliance.
CIN L24110MH1981PLC025884 Incorporated 18 December 1981 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Listed - BSE: 524774 Public Limited Company pharma
Data last updated
Revenue · FY 2026
₹500.95 Cr
▲ 36.03% YoY
Computed EBITDA · FY 2026
₹87.42 Cr
▲ 105.69% YoY
Net profit · FY 2026
₹48.13 Cr
▲ 127.83% YoY
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹3.09 Cr
Issued & subscribed
Open charges
₹117.75 Cr
Satisfied ₹53.89 Cr
Company age
45 yrs
Est. 1981
Employees · EPFO
363
Latest available

About Ngl Fine-Chem Limited

Data last updated: 15 July 2026

Ngl Fine-Chem Limited is a public limited company based in Mumbai, Maharashtra, India. It specialises in animal pharmaceuticals and healthcare, a part of the broader pharmaceuticals sector. Incorporated on 18 December 1981, the company has been in operation for over 45 years.

Registered with ROC Mumbai under CIN L24110MH1981PLC025884. Listed on BSE: 524774.

Capital: an authorised share capital of ₹5 Cr and a paid-up capital of ₹3.09 Cr. Formerly known as Angel Organic Chemicals Pvt Ltd and Angel Organic Chemicals Ltd. It is led by directors including Ajita Rahul Nachane and Rahul Jayant Nachane.

Last AGM: 19 August 2025. Financial statements filed for year ended 31 March 2025. Office: 301 E Square Subhash Road Vile Parle (East), Mumbai, Maharashtra, India – 400057.

As per NSE-filed consolidated financials for FY 2026, the company reported a revenue of ₹500.95 Cr, a growth of 36.03% compared to the previous year. The net worth stands at ₹329.23 Cr (up 16.57% YoY). Total assets are valued at ₹545.5 Cr (up 25.87% YoY).

The company has a workforce of approximately 363 employees as per the latest available data. Its group structure includes 1 subsidiary.

The company is associated with 1 brand - Ngl Fine Chem. As per MCA filings, the company has open charges of ₹117.75 Cr and satisfied charges of ₹53.89 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website nglfinechem.com.

Company Details of Ngl Fine-Chem Limited
CIN L24110MH1981PLC025884
Registration Number 025884
Incorporation Date 18 December 1981
ROC Mumbai
Listing Status Listed (BSE: 524774)
Company Status Active
Date of Last AGM 19 August 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Rahul Jayant Nachane Managing Director Rajesh Narayan Lawande Whole-Time Director Ajita Rahul Nachane Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    nglfinechem.com
  • Social Media
  • Registered Address
    301 E Square Subhash Road Vile Parle (East), Mumbai, Maharashtra, India – 400057
  • Industry
    Pharma, Animal Pharmaceuticals & Healthcare, Drug Formulation & Development
Company report
Ngl Fine-Chem Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Ngl Fine-Chem Limited report

Financials, compliance, directors, charges, ownership and filings for Ngl Fine-Chem Limited in one report.

10-year financials Directors & ownership Charges & compliance

Name History of Ngl Fine-Chem Limited

Ngl Fine-Chem Limited has undergone 2 name changes throughout its history. The company was previously known as Angel Organic Chemicals Pvt Ltd, and Angel Organic Chemicals Ltd. The current legal name is Ngl Fine-Chem Limited, reflecting the company's evolution and rebranding over time.

Company Name Status
Ngl Fine-Chem Limited Current
Angel Organic Chemicals Pvt Ltd Previous
Angel Organic Chemicals Ltd Previous

CIN History of Ngl Fine-Chem Limited

Ngl Fine-Chem Limited has one previous CIN (Corporate Identification Number): U24110MH1981PTC025884. The current CIN is L24110MH1981PLC025884, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L24110MH1981PLC025884 Current
U24110MH1981PTC025884 Previous

Associated Brands with Ngl Fine-Chem Limited

Ngl Fine-Chem Limited operates one associated brand: NGL Fine Chem. These brands represent Ngl Fine-Chem Limited's diversified market presence and brand portfolio.

Brand Description Website
NGL Fine Chem
CDMO specializing in multi stage organic synthesis of generic APIs and fine chemicals nglfinechem.com

Competitors & Alternatives of Ngl Fine-Chem Limited

Brands and companies operating in the same space as Ngl Fine-Chem Limited include Laurus Labs, Symbiotec, Sterling Pharma Solutions and 5 more.

Competitor Description Location Founded
Laurus Labs Laurus Labs Pharmaceutical and biotechnology company Hyderabad, India, India 2005
Symbiotec Symbiotec Non-sterile steroid hormone-based APIs and intermediates are manufactured. Indore, India, India 2002
Sterling Pharma Solutions Sterling Pharma Solutions Contract development, manufacturing, and analytical services for APIs are offered. Dudley, United Kingdom, United Kingdom 2016
Provepharm Life Solutions Provepharm Life Solutions APIs and drug products are developed and valorized in pharmaceuticals. Marseille, France, France 1998
Apicore Apicore APIs are manufactured and custom synthesis services are provided. Somerset, United States, United States 2004
SeQuent SeQuent APIs are developed and manufactured for therapeutic areas. Bengaluru, India, India 2002
Jubilant Pharma Jubilant Pharma Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. Noida, India, India 1978
Bellen Chemistry Bellen Chemistry APIs and intermediates are researched and manufactured, specializing in heterocycles. Beijing, China, China 2007

Business Activity of Ngl Fine-Chem Limited

Ngl Fine-Chem Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Ngl Fine-Chem Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Ngl Fine-Chem Limited

Ngl Fine-Chem Limited is audited by M/s. Manek & Associates (ICAI peer reviewed, certificate valid till 2029-01-31) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
M/s. Manek & Associates (ICAI peer reviewed, certificate valid till 2029-01-31) FY 2026 Declaration of unmodified opinion

Board of Directors of Ngl Fine-Chem Limited

Ngl Fine-Chem Limited is currently managed by 6 directors, with 8 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Ajita Rahul Nachane
Also directs: Tele Access E-Services Private Limited
Director 15 Sep 2014 11 Years 10 Months Current
Rahul Jayant Nachane
Also directs: Macrotech Polychem Private Limited, Nupur Remedies Pvt Ltd, Vetfar Pharmaceuticals Private Limited and 1 more
Managing Director 04 Jan 1993 33 Years 7 Months Current
Sarala Menon
Also directs: Aretian Business Consulting Llp
Director 14 Dec 2021 4 Years 8 Months Current
Rajesh Narayan Lawande
Also directs: Macrotech Polychem Private Limited, Nupur Remedies Pvt Ltd, Vetfar Pharmaceuticals Private Limited
Whole-Time Director 01 Jun 2015 11 Years 2 Months Current
Sudhir Ramchandra Deo
Also directs: Navin Fluorine International Limited
Director 22 May 2025 1 Years 2 Months Current
Dhananjay Narendra Mungale
Also directs: Kalpataru Projects International Limited, Lichfl Asset Management Company Limited, Dsp Asset Managers Private Limited and 3 more
Director 18 Mar 2024 2 Years 4 Months Current
View all directors

Financials of Ngl Fine-Chem Limited FY 2026 filings available

Ngl Fine-Chem Limited reported revenue of ₹500.95 Cr (up 36.03% YoY) for FY 2026.

Revenue · FY 2026
₹500.95 Cr ▲ 36.03%
Profit · FY 2026
₹48.13 Cr ▲ 127.83%
Computed EBITDA · FY 2026
₹87.42 Cr ▲ 105.69%
Revenue₹ Cr · Consolidated0200400600FY 2023: ₹278 Cr278FY 2023FY 2024: ₹339 Cr · +21.8% YoY339+21.8%FY 2024FY 2025: ₹368 Cr · +8.7% YoY368+8.7%FY 2025FY 2026: ₹501 Cr · +36% YoY501+36%FY 2026
Net Profit₹ Cr · Consolidated0204060FY 2023: ₹20 Cr20.5FY 2023FY 2024: ₹41 Cr · +101.6% YoY41.3+101.6%FY 2024FY 2025: ₹21 Cr · -48.9% YoY21.1-48.9%FY 2025FY 2026: ₹48 Cr · +127.8% YoY48.1+127.8%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year050100150Q1'25: ₹91 Cr · +27.7% YoY90.8+27.7%Q1'25Q2'25: ₹93 Cr · +16.6% YoY93.5+16.6%Q2'25Q3'25: ₹89 Cr · +1.3% YoY89.1+1.3%Q3'25Q4'25: ₹95 Cr · -4.8% YoY95-4.8%Q4'25Q1'26: ₹104 Cr · +14.8% YoY104+14.8%Q1'26Q2'26: ₹120 Cr · +28.6% YoY120+28.6%Q2'26Q3'26: ₹128 Cr · +43.1% YoY128+43.1%Q3'26Q4'26: ₹149 Cr · +57.1% YoY149+57.1%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Revenue from Operations ₹500.95 Cr ₹368.26 Cr ₹338.69 Cr ₹278.08 Cr
Other Income ₹14.73 Cr ₹8.63 Cr ₹14.13 Cr ₹5.53 Cr
Total Income ₹515.68 Cr ₹376.89 Cr ₹352.82 Cr ₹283.61 Cr
Cost of Materials Consumed ₹247.22 Cr ₹182.41 Cr ₹170.81 Cr ₹116.41 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0
Changes in Inventories -₹7.73 Cr -₹59,000 -₹12.13 Cr ₹23.91 Cr
Employee Benefit Expense ₹65.5 Cr ₹55.55 Cr ₹45.12 Cr ₹36.87 Cr
Finance Costs ₹4.47 Cr ₹2.33 Cr ₹1.34 Cr ₹1.2 Cr
Depreciation & Amortisation ₹19.58 Cr ₹12.45 Cr ₹11.64 Cr ₹11.29 Cr
Other Expenses ₹123.27 Cr ₹96.43 Cr ₹81.62 Cr ₹66.57 Cr
Total Expenses ₹452.32 Cr ₹349.17 Cr ₹298.4 Cr ₹256.25 Cr
Profit Before Exceptional Items & Tax ₹63.37 Cr ₹27.71 Cr ₹54.42 Cr ₹27.36 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹63.37 Cr ₹27.71 Cr ₹54.42 Cr ₹27.36 Cr
Total Tax Expense ₹15.24 Cr ₹6.59 Cr ₹13.1 Cr ₹6.87 Cr
Net Profit ₹48.13 Cr ₹21.12 Cr ₹41.32 Cr ₹20.5 Cr
  attributable to Owners ₹0 - ₹0 ₹0
  attributable to NCI ₹0 - ₹0 ₹0
Other Comprehensive Income -₹24.23 Lakh -₹24.04 Lakh -₹15.28 Lakh -₹8.4 Lakh
Total Comprehensive Income ₹47.88 Cr ₹20.88 Cr ₹41.16 Cr ₹20.41 Cr
EBITDA (computed) ₹87.42 Cr ₹42.5 Cr ₹67.4 Cr ₹39.85 Cr
Basic EPS ₹77.90 ₹34.19 ₹66.88 ₹33.18
Diluted EPS ₹77.90 ₹34.19 ₹66.88 ₹33.18
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹545.5 Cr ₹433.39 Cr ₹355.54 Cr ₹287.08 Cr
Non-current Assets ₹269.11 Cr ₹198.01 Cr ₹142.87 Cr ₹124.42 Cr
Current Assets ₹276.39 Cr ₹235.38 Cr ₹212.67 Cr ₹162.66 Cr
Property, Plant & Equipment ₹163.8 Cr ₹142.12 Cr ₹85.3 Cr ₹87.59 Cr
Inventories ₹70.28 Cr ₹51.27 Cr ₹43.3 Cr ₹26.99 Cr
Trade Receivables ₹130.88 Cr ₹81.55 Cr ₹89.62 Cr ₹65.87 Cr
Cash & Equivalents ₹2.81 Cr ₹58.33 Lakh ₹39.52 Lakh ₹7.83 Cr
Equity (Net Worth) ₹329.23 Cr ₹282.43 Cr ₹262.63 Cr ₹222.55 Cr
Equity Share Capital ₹3.09 Cr ₹3.09 Cr ₹3.09 Cr ₹3.09 Cr
Borrowings (Non-current) ₹56.4 Cr ₹25.34 Cr ₹74.48 Lakh ₹2.07 Cr
Borrowings (Current) ₹52.02 Cr ₹47.82 Cr ₹31.7 Cr ₹28.41 Cr
Total Debt (computed) ₹108.43 Cr ₹73.15 Cr ₹32.44 Cr ₹30.48 Cr
Current Liabilities ₹150.01 Cr ₹118.97 Cr ₹86.59 Cr ₹58.29 Cr
Total Liabilities ₹216.27 Cr ₹150.96 Cr ₹92.9 Cr ₹64.53 Cr
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Operating Cash Flow ₹43.32 Cr ₹35.82 Cr ₹20.47 Cr ₹35.29 Cr
Investing Cash Flow -₹70.59 Cr -₹34.55 Cr -₹26.82 Cr -₹27.02 Cr
Financing Cash Flow ₹29.55 Cr -₹1.08 Cr -₹1.08 Cr -₹1.08 Cr
Capital Expenditure ₹89.85 Cr ₹130.77 Cr ₹28.52 Cr ₹31.41 Cr
Free Cash Flow (computed) -₹46.53 Cr -₹94.95 Cr -₹8.06 Cr ₹3.88 Cr
Dividends Paid ₹1.08 Cr ₹1.08 Cr ₹1.08 Cr ₹1.08 Cr
Net Change in Cash ₹2.81 Cr ₹18.81 Lakh -₹7.43 Cr ₹7.18 Cr
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹149.23 Cr ₹127.51 Cr ₹120.26 Cr ₹104.19 Cr ₹94.97 Cr ₹89.1 Cr ₹93.48 Cr ₹90.75 Cr ₹99.76 Cr ₹87.95 Cr ₹80.18 Cr ₹71.04 Cr
Other Income ₹2.46 Cr ₹4.61 Cr ₹2.05 Cr ₹6.35 Cr -₹96.56 Lakh -₹13.19 Lakh ₹5.12 Cr ₹5.88 Cr ₹3.68 Cr ₹3.68 Cr ₹3.22 Cr ₹3.32 Cr
Total Income ₹151.69 Cr ₹132.12 Cr ₹122.31 Cr ₹110.54 Cr ₹94.01 Cr ₹88.97 Cr ₹98.6 Cr ₹96.64 Cr ₹103.44 Cr ₹91.63 Cr ₹83.4 Cr ₹74.36 Cr
Cost of Materials Consumed ₹67.3 Cr ₹62.71 Cr ₹61.89 Cr ₹55.4 Cr ₹51.18 Cr ₹47.93 Cr ₹41.8 Cr ₹41.55 Cr ₹51.78 Cr ₹46.07 Cr ₹40.49 Cr ₹32.48 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 -₹3.51 Cr ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories ₹3.6 Cr -₹3.19 Cr -₹4.62 Cr ₹0 -₹3.38 Cr -₹4.4 Cr ₹2.37 Cr ₹5.63 Cr -₹4.47 Cr -₹4.82 Cr -₹4.29 Cr ₹1.45 Cr
Employee Benefit Expense ₹16.96 Cr ₹17.08 Cr ₹15.7 Cr ₹15.76 Cr ₹14.25 Cr ₹14.66 Cr ₹14.72 Cr ₹11.92 Cr ₹12.09 Cr ₹11.52 Cr ₹10.9 Cr ₹10.61 Cr
Finance Costs ₹1.01 Cr ₹1.07 Cr ₹1.16 Cr ₹1.22 Cr ₹97.36 Lakh ₹60.05 Lakh ₹31.66 Lakh ₹44.34 Lakh ₹48.79 Lakh ₹27.5 Lakh ₹36.21 Lakh ₹24.29 Lakh
Depreciation & Amortisation ₹5.05 Cr ₹5.18 Cr ₹5.09 Cr ₹4.27 Cr ₹3.32 Cr ₹3.1 Cr ₹3.03 Cr ₹3 Cr ₹2.92 Cr ₹2.94 Cr ₹2.89 Cr ₹2.86 Cr
Other Expenses ₹39.96 Cr ₹28.6 Cr ₹30.14 Cr ₹25.56 Cr ₹26.6 Cr ₹25.81 Cr ₹23.03 Cr ₹22.31 Cr ₹24.54 Cr ₹21.31 Cr ₹19.11 Cr ₹16.64 Cr
Total Expenses ₹133.88 Cr ₹111.45 Cr ₹109.35 Cr ₹98.7 Cr ₹92.95 Cr ₹87.7 Cr ₹85.27 Cr ₹84.85 Cr ₹87.35 Cr ₹77.3 Cr ₹69.46 Cr ₹64.28 Cr
Profit Before Exceptional Items & Tax ₹17.81 Cr ₹20.67 Cr ₹12.96 Cr ₹11.84 Cr ₹1.06 Cr ₹1.27 Cr ₹13.33 Cr ₹11.79 Cr ₹16.09 Cr ₹14.33 Cr ₹13.94 Cr ₹10.08 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹17.81 Cr ₹20.67 Cr ₹12.96 Cr ₹11.84 Cr ₹1.06 Cr ₹1.27 Cr ₹13.33 Cr ₹11.79 Cr ₹16.09 Cr ₹14.33 Cr ₹13.94 Cr ₹10.08 Cr
Total Tax Expense ₹4.33 Cr ₹4.98 Cr ₹3.34 Cr ₹2.6 Cr ₹51.65 Lakh -₹1.13 Lakh ₹3.52 Cr ₹2.57 Cr ₹3.77 Cr ₹4.3 Cr ₹3.46 Cr ₹1.58 Cr
Net Profit ₹13.49 Cr ₹15.69 Cr ₹9.63 Cr ₹9.24 Cr ₹54.37 Lakh ₹1.28 Cr ₹9.81 Cr ₹9.22 Cr ₹12.32 Cr ₹10.03 Cr ₹10.48 Cr ₹8.51 Cr
  attributable to Owners ₹0 ₹0 - ₹0 - ₹0 ₹0 ₹0 ₹0 ₹0 - ₹0
  attributable to NCI ₹0 ₹0 - ₹0 - ₹0 ₹0 ₹0 ₹0 ₹0 - ₹0
Other Comprehensive Income -₹9.32 Lakh -₹4.22 Lakh ₹13.78 Lakh -₹24.47 Lakh -₹1.14 Lakh ₹6.22 Lakh -₹29.99 Lakh ₹87,000 -₹50,000 ₹3.04 Lakh ₹5.59 Lakh -₹23.4 Lakh
Total Comprehensive Income ₹13.39 Cr ₹15.65 Cr ₹9.76 Cr ₹9 Cr ₹53.23 Lakh ₹1.34 Cr ₹9.51 Cr ₹9.23 Cr ₹12.32 Cr ₹10.06 Cr ₹10.53 Cr ₹8.27 Cr
EBITDA (computed) ₹23.87 Cr ₹26.93 Cr ₹19.21 Cr ₹17.33 Cr ₹5.35 Cr ₹4.96 Cr ₹16.67 Cr ₹15.24 Cr ₹19.5 Cr ₹17.55 Cr ₹17.19 Cr ₹13.19 Cr
Basic EPS ₹21.83 ₹25.40 ₹15.58 ₹14.96 ₹0.88 ₹2.07 ₹15.88 ₹14.92 ₹19.95 ₹16.24 ₹16.96 ₹13.77
Diluted EPS ₹21.83 ₹25.40 ₹15.58 ₹14.96 ₹0.88 ₹2.07 ₹15.88 ₹14.92 ₹19.95 ₹16.24 ₹16.96 ₹13.77
Latest 12 quarters shown of 16 on record.
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Revenue from Operations ₹488.77 Cr ₹359.29 Cr ₹328.97 Cr ₹275.05 Cr
Other Income ₹14.85 Cr ₹9.76 Cr ₹15.9 Cr ₹7.61 Cr
Total Income ₹503.63 Cr ₹369.05 Cr ₹344.87 Cr ₹282.66 Cr
Cost of Materials Consumed ₹249.63 Cr ₹183.8 Cr ₹166.58 Cr ₹116.58 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0
Changes in Inventories -₹8.39 Cr ₹1.36 Cr -₹12.06 Cr ₹23.29 Cr
Employee Benefit Expense ₹60.25 Cr ₹50.71 Cr ₹41.32 Cr ₹34.25 Cr
Finance Costs ₹4.4 Cr ₹2.31 Cr ₹1.34 Cr ₹1.2 Cr
Depreciation & Amortisation ₹16.3 Cr ₹9.27 Cr ₹8.15 Cr ₹7.9 Cr
Other Expenses ₹126.81 Cr ₹97.73 Cr ₹88.83 Cr ₹72.85 Cr
Total Expenses ₹449.01 Cr ₹345.17 Cr ₹294.17 Cr ₹256.07 Cr
Profit Before Exceptional Items & Tax ₹54.62 Cr ₹23.88 Cr ₹50.71 Cr ₹26.6 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹54.62 Cr ₹23.88 Cr ₹50.71 Cr ₹26.6 Cr
Total Tax Expense ₹12.99 Cr ₹5.75 Cr ₹12.19 Cr ₹6.48 Cr
Net Profit ₹41.63 Cr ₹18.13 Cr ₹38.52 Cr ₹20.12 Cr
Other Comprehensive Income -₹22.8 Lakh -₹24.31 Lakh -₹15.32 Lakh -₹8.19 Lakh
Total Comprehensive Income ₹41.4 Cr ₹17.89 Cr ₹38.37 Cr ₹20.04 Cr
EBITDA (computed) ₹75.32 Cr ₹35.46 Cr ₹60.19 Cr ₹35.7 Cr
Basic EPS ₹67.39 ₹29.35 ₹62.35 ₹32.56
Diluted EPS ₹67.39 ₹29.35 ₹62.35 ₹32.56
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹529.63 Cr ₹425.76 Cr ₹353.05 Cr ₹288.11 Cr
Non-current Assets ₹264.38 Cr ₹195.89 Cr ₹149.35 Cr ₹128.92 Cr
Current Assets ₹265.25 Cr ₹229.87 Cr ₹203.69 Cr ₹159.19 Cr
Property, Plant & Equipment ₹143.68 Cr ₹119.49 Cr ₹60.01 Cr ₹59.32 Cr
Inventories ₹67.63 Cr ₹49.07 Cr ₹42.6 Cr ₹26.96 Cr
Trade Receivables ₹125.47 Cr ₹79.77 Cr ₹83.13 Cr ₹65.18 Cr
Cash & Equivalents ₹54.94 Lakh ₹57.36 Lakh ₹38.68 Lakh ₹7.82 Cr
Equity (Net Worth) ₹319.94 Cr ₹279.61 Cr ₹262.81 Cr ₹225.52 Cr
Equity Share Capital ₹3.09 Cr ₹3.09 Cr ₹3.09 Cr ₹3.09 Cr
Borrowings (Non-current) ₹56.4 Cr ₹25.34 Cr ₹74.48 Lakh ₹2.07 Cr
Borrowings (Current) ₹51.12 Cr ₹46.84 Cr ₹31.7 Cr ₹28.41 Cr
Total Debt (computed) ₹107.53 Cr ₹72.18 Cr ₹32.44 Cr ₹30.48 Cr
Current Liabilities ₹144.03 Cr ₹114.61 Cr ₹84.36 Cr ₹56.65 Cr
Total Liabilities ₹209.69 Cr ₹146.15 Cr ₹90.24 Cr ₹62.59 Cr
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Operating Cash Flow ₹34.73 Cr ₹17.02 Cr ₹11.14 Cr ₹31.89 Cr
Investing Cash Flow -₹64.57 Cr -₹15.75 Cr -₹17.49 Cr -₹23.62 Cr
Financing Cash Flow ₹29.87 Cr -₹1.08 Cr -₹1.08 Cr -₹1.08 Cr
Capital Expenditure ₹89.07 Cr ₹73.76 Cr ₹28.01 Cr ₹29.11 Cr
Free Cash Flow (computed) -₹54.33 Cr -₹56.75 Cr -₹16.87 Cr ₹2.78 Cr
Dividends Paid ₹1.08 Cr ₹1.08 Cr ₹1.08 Cr ₹1.08 Cr
Net Change in Cash ₹2.58 Lakh ₹18.66 Lakh -₹7.44 Cr ₹7.82 Cr
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹144.75 Cr ₹126.33 Cr ₹116.84 Cr ₹100.86 Cr ₹93.02 Cr ₹86.83 Cr ₹91.41 Cr ₹88.03 Cr ₹95.61 Cr ₹84.81 Cr ₹79.44 Cr ₹69.11 Cr
Other Income ₹2.51 Cr ₹4.69 Cr ₹2.41 Cr ₹6.55 Cr -₹79.02 Lakh ₹15.26 Lakh ₹5.43 Cr ₹6.27 Cr ₹4.16 Cr ₹4.19 Cr ₹3.76 Cr ₹3.8 Cr
Total Income ₹147.26 Cr ₹131.02 Cr ₹119.25 Cr ₹107.41 Cr ₹92.23 Cr ₹86.98 Cr ₹96.84 Cr ₹94.3 Cr ₹99.77 Cr ₹89 Cr ₹83.2 Cr ₹72.92 Cr
Cost of Materials Consumed ₹68.07 Cr ₹63.99 Cr ₹63.55 Cr ₹55.07 Cr ₹51.78 Cr ₹49.82 Cr ₹41.77 Cr ₹40.42 Cr ₹50.01 Cr ₹45.07 Cr ₹39.96 Cr ₹31.54 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 -₹4.05 Cr ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 -₹4.12 Cr ₹0
Changes in Inventories ₹2.84 Cr -₹2.48 Cr -₹5.74 Cr ₹0 -₹2.86 Cr -₹4.73 Cr ₹3.03 Cr ₹5.91 Cr -₹4.52 Cr -₹5.07 Cr ₹0 ₹1.65 Cr
Employee Benefit Expense ₹15.69 Cr ₹15.72 Cr ₹14.37 Cr ₹14.47 Cr ₹12.94 Cr ₹13.25 Cr ₹13.67 Cr ₹10.85 Cr ₹10.95 Cr ₹10.53 Cr ₹10.05 Cr ₹9.79 Cr
Finance Costs ₹99.48 Lakh ₹1.06 Cr ₹1.15 Cr ₹1.21 Cr ₹94.69 Lakh ₹60.05 Lakh ₹31.66 Lakh ₹44.34 Lakh ₹45.8 Lakh ₹27.5 Lakh ₹36.21 Lakh ₹24.29 Lakh
Depreciation & Amortisation ₹4.24 Cr ₹4.35 Cr ₹4.26 Cr ₹3.45 Cr ₹2.53 Cr ₹2.3 Cr ₹2.3 Cr ₹2.14 Cr ₹2.06 Cr ₹2.07 Cr ₹2.02 Cr ₹2 Cr
Other Expenses ₹40.55 Cr ₹29 Cr ₹31 Cr ₹27.55 Cr ₹27.25 Cr ₹24.93 Cr ₹22.32 Cr ₹24.53 Cr ₹26.57 Cr ₹23.33 Cr ₹20.42 Cr ₹18.53 Cr
Total Expenses ₹132.38 Cr ₹111.65 Cr ₹108.59 Cr ₹97.7 Cr ₹92.59 Cr ₹86.17 Cr ₹83.41 Cr ₹84.3 Cr ₹85.54 Cr ₹76.21 Cr ₹68.69 Cr ₹63.75 Cr
Profit Before Exceptional Items & Tax ₹14.88 Cr ₹19.37 Cr ₹10.66 Cr ₹9.71 Cr -₹36.03 Lakh ₹81.11 Lakh ₹13.43 Cr ₹10 Cr ₹14.24 Cr ₹12.8 Cr ₹14.52 Cr ₹9.16 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹14.88 Cr ₹19.37 Cr ₹10.66 Cr ₹9.71 Cr -₹36.03 Lakh ₹81.11 Lakh ₹13.43 Cr ₹10 Cr ₹14.24 Cr ₹12.8 Cr ₹14.52 Cr ₹9.16 Cr
Total Tax Expense ₹3.52 Cr ₹4.64 Cr ₹2.76 Cr ₹2.07 Cr ₹16.02 Lakh ₹2.83 Lakh ₹3.39 Cr ₹2.18 Cr ₹3.39 Cr ₹3.9 Cr ₹3.55 Cr ₹1.36 Cr
Net Profit ₹11.35 Cr ₹14.74 Cr ₹7.9 Cr ₹7.64 Cr -₹52.05 Lakh ₹78.28 Lakh ₹10.04 Cr ₹7.83 Cr ₹10.85 Cr ₹8.9 Cr ₹10.97 Cr ₹7.81 Cr
Other Comprehensive Income -₹7.39 Lakh -₹4.39 Lakh ₹13.1 Lakh -₹24.11 Lakh -₹1.27 Lakh ₹5.98 Lakh -₹29.34 Lakh ₹33,000 -₹16,000 ₹2.66 Lakh ₹5.34 Lakh -₹23.16 Lakh
Total Comprehensive Income ₹11.28 Cr ₹14.69 Cr ₹8.03 Cr ₹7.4 Cr -₹53.32 Lakh ₹84.26 Lakh ₹9.75 Cr ₹7.83 Cr ₹10.85 Cr ₹8.92 Cr ₹11.02 Cr ₹7.57 Cr
EBITDA (computed) ₹20.11 Cr ₹24.78 Cr ₹16.08 Cr ₹14.37 Cr ₹3.12 Cr ₹3.71 Cr ₹16.05 Cr ₹12.59 Cr ₹16.76 Cr ₹15.14 Cr ₹16.89 Cr ₹11.4 Cr
Basic EPS ₹18.38 ₹23.85 ₹12.78 ₹12.37 ₹-0.84 ₹1.27 ₹16.26 ₹12.67 ₹17.56 ₹14.40 ₹17.76 ₹12.63
Diluted EPS ₹18.38 ₹23.85 ₹12.78 ₹12.37 ₹-0.84 ₹1.27 ₹16.26 ₹12.67 ₹17.56 ₹14.40 ₹17.76 ₹12.63
Latest 12 quarters shown of 16 on record.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Ngl Fine-Chem Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Ngl Fine-Chem Limited

As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 72.74%, foreign institutional investors hold 0.03%, retail and other public shareholders hold 27.24% of Ngl Fine-Chem Limited. The company had 12,516 shareholders on record.

Promoters: 72.74%FII (Foreign Institutional): 0.03%Retail & Others: 27.24%
Mar 2026
QUARTER
72.74% Promoters
0.03% FII (Foreign Institutional)
27.24% Retail & Others
Promoter holding - history
Now 72.74% · Mar 2026High 73.81% · May 2022Low 72.74% · Mar 2024
71%72%73%74%75%May 2022Mar 2023Mar 2024Mar 2025Mar 2026May 2022: 73.81%Jun 2022: 73.81%Sep 2022: 73.81%Dec 2022: 73.81%Mar 2023: 73.53%Jun 2023: 73.53%Sep 2023: 73.06%Dec 2023: 73.06%Mar 2024: 72.74%Jun 2024: 72.74%Sep 2024: 72.74%Dec 2024: 72.74%Mar 2025: 72.74%Jun 2025: 72.74%Sep 2025: 72.74%Dec 2025: 72.74%Mar 2026: 72.74%73.81%72.74%72.74%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters72.74%72.74%72.74%72.74%72.74%72.74%
Public27.26%27.26%27.26%27.26%27.26%27.26%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024Mar 2023
Promoters72.74%72.74%72.74%73.53%
Public27.26%27.26%27.26%26.47%
Promoter change (YoY, %pts)+0.00+0.00-0.79-

Board & Governance of Ngl Fine-Chem Limited

As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Ngl Fine-Chem Limited has 6 directors - 3 independent and 2 executive. The board is chaired by DHANANJAY MUNGALE.

DirectorPositionOn board sinceListed boards
RAHUL NACHANE Executive Director · MD 1993-01-04 1
RAJESH LAWANDE Executive Director 2015-06-01 1
AJITA NACHANE Non-Executive - Non Independent Director 2014-09-15 1
DHANANJAY MUNGALE Non-Executive - Independent Director · Chairperson 2024-03-18 2
SUDHIR DEO Non-Executive - Independent Director 2025-05-22 2
SARALA MENON Non-Executive - Independent Director 2021-12-14 1
Board Committees
CommitteeMembers
Audit Committee DHANANJAY MUNGALE (Chairperson), RAJESH LAWANDE, SUDHIR DEO, SARALA MENON
Nomination and remuneration committee SARALA MENON (Chairperson), AJITA NACHANE, DHANANJAY MUNGALE
Stakeholders Relationship Committee SARALA MENON (Chairperson), RAHUL NACHANE, AJITA NACHANE
Risk Management Committee RAHUL NACHANE (Chairperson), RAJESH LAWANDE, AJITA NACHANE, SUDHIR DEO
Corporate Social Responsibility Committee SARALA MENON (Chairperson), RAJESH LAWANDE, AJITA NACHANE
ADMINISTRATIVE COMMITTEE RAHUL NACHANE (Chairperson), RAJESH LAWANDE, AJITA NACHANE

Group Structure of Ngl Fine-Chem Limited

Ngl Fine-Chem Limited has 1 subsidiary company. This group structure data is as of FY 2023. The corporate group structure reflects Ngl Fine-Chem Limited's business expansion strategy and organizational complexity.

1
Subsidiary companies
Key Subsidiaries
Company Name CIN Shares Held
Macrotech Polychem Private Limited U24100MH2004PTC145189 -

Showing major subsidiaries. Total: 1.

Charges & Borrowings of Ngl Fine-Chem Limited

Open charges
₹117.75 Cr
Satisfied charges
₹53.89 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹67.25 Cr
Others₹50.50 Cr
Latest charge details
DateLenderAmountStatus
29 Nov 2023 Hdfc Bank Limited ₹25 Lakh Open
02 Aug 2022 Others ₹50.5 Cr Open
07 Dec 2015 Hdfc Bank Limited ₹67 Cr Open
10 Mar 2022 Hdfc Bank Limited ₹30 Lakh Satisfied
30 Aug 2021 Hdfc Bank Limited ₹19 Lakh Satisfied

Total charge records: 30 View all charges

Employees and EPFO Compliance at Ngl Fine-Chem Limited

Ngl Fine-Chem Limited has a workforce of 363 employees as of Apr 08, 2024.

Employee count
363
Active EPFO establishments
2
Employee growth
6.76%
Premium access

Employee and EPFO history for Ngl Fine-Chem Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Ngl Fine-Chem Limited

Premium access

GST registrations and filing compliance for Ngl Fine-Chem Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Ngl Fine-Chem Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Ngl Fine-Chem Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Ngl Fine-Chem Limited

Premium access

MSME payment history for Ngl Fine-Chem Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Ngl Fine-Chem Limited

Premium access

Corporate group structure for Ngl Fine-Chem Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Ngl Fine-Chem Limited

Premium access

MCA filings and documents for Ngl Fine-Chem Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Ngl Fine-Chem Limited

Directors
11 Feb 2026
Shivam Jagdish Gharat was appointed as a Company Secretary on 11 Feb 2026 & has been associated with this company since 6 months 3 days.
Charges
21 Aug 2025
A charge registered on 10 Mar 2022 via Charge ID 100555031 with Hdfc Bank Limited was fully satisfied on 21 Aug 2025.
Activity
19 Aug 2025
Ngl Fine-Chem Limited last Annual general meeting of members was held on 19 Aug 2025 as per latest MCA records.
Directors
22 May 2025
Sudhir Ramchandra Deo was appointed as a Director on 22 May 2025 & has been associated with this company since 1 year 2 months.
Activity
31 Mar 2025
Ngl Fine-Chem Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Charges
13 Mar 2025
A charge with Others of Rs. 50.50 Cr registered on 02 Aug 2022 with Charge ID 100603458 was modified on 13 Mar 2025.

Recent News on Ngl Fine-Chem Limited

Stocks that will see action today: February 27, 2025
27 Feb 2025 · Thehindubusinessline

Frequently Asked Questions about Ngl Fine-Chem Limited

Ngl Fine-Chem Limited is an active public limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 18 December 1981 (45+ years old) and is registered under CIN L24110MH1981PLC025884. Listed on BSE: 524774. The company has 363 employees.

Ngl Fine-Chem Limited reported revenue of ₹500.95 Cr for FY 2026 (up 36.03% YoY) based on consolidated NSE filings.

The current directors of Ngl Fine-Chem Limited are:

The primary industry of Ngl Fine-Chem Limited is pharma. The company specifically operates in animal pharmaceuticals and healthcare. The company is currently active in this sector.

Yes. Ngl Fine-Chem Limited is listed on BSE with code 524774.

Ngl Fine-Chem Limited can be reached at the registered office: 301 E Square Subhash Road Vile Parle East, Mumbai, Maharashtra, India – 400057, or through the website nglfinechem.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available